Specialty Drug ‘Doom Loop:’ Manufacturers Fight Against Becoming Primary Payers For Own Drugs

 
• By Cathy Kelly
  
The Conflict Between Payers and Manufacturers Can Be Tough On Patients. • Source: Shutterstock

More from Market Access

More from Pink Sheet